CfP2

Platform technologies to enable rapid vaccine development for epidemic prone infections

In this two-step call, CEPI asks for submission of proposals for vaccine platform technologies that enable rapid vaccine development, rapid scale up, and quick time to immunity for reactive use in outbreaks of novel or previously unrecognised viruses. Proposals can include new platforms with the potential for rapidly making a vaccine using materials generally regarded as safe (GRAS), or those compressing the time of an existing (proven) platform to make it more responsive in an unknown threat situation. During the proposed project period, we encourage developers to target the following timelines:

  1. Target a 16-week timeframe from identification of antigen to product release for clinical trials
  2. Target a 6-week timeframe from administration of first dose to achievement of clinical benefit (i.e. immune response likely to result in clinical benefit)
  3. Produce 100,000 vaccine doses within 8 weeks to impact an emerging outbreak (i.e. from Go-decision to scale-up to production, fill, finish, and release)

Timeline

  • Deadline for submission of step 1 proposals: 4 p.m. CEST 17 October 2017

If you have any unsolved queries about the online application form on October 17th please call the Research Council hotline between 8 a.m. and 4 p.m. CEST on +47 22 03 72 00

Responses to CEPI's second call for proposals

On 1st September, CEPI launched its Second Call for Proposals (CfP) on Vaccine platform technologies to promote the objective of developing development of real time response capabilities to novel emerging threats, and immunize at-risk populations against emerging infectious diseases, potentially resulting in great public health impact by rapidly limiting or ending outbreaks.

In response to this Call for Proposals, the Secretariat received over 35 applications by the deadline of 17 October, with a broad diversity displayed in the vaccine platform technologies being proposed, including both novel concepts and established technologies. All eligible submissions are now being evaluated, and shortlisted applicants will be notified in December to submit detailed proposals in early 2018.

Similar to our previous call, applicants and their partners are from North America, South America, Europe, Africa, the Middle East, Asia and Australia, representing academic institutions, biotechs, large pharmaceutical companies and Product Development Partnerships.”

CfP2 call text

Call for proposals on platform technology

This document describes the scope, requirements and processes for proposal submission, review, and selection for funding.

PDF FORMAT - 272KB

Download

Application process

The CEPI secretariat is collaborating with the Research Council of Norway (RCN) by using their established online application system for submissions.

Please note that:

  • Only proposal forms and related documents submitted through this system will be considered.
  • CEPI encourages applicants to familiarise themselves with the online application portal in the weeks leading up to the deadline so applications are submitted as smoothly as possible.
  • The deadline is definite and the portal will not allow submission after the CfP deadline.

Here you can access the CEPI online application form:

CEPI online application form

Guidelines for online application

PDF FORMAT - 815KB

Download

Templates

As part of your proposal, please complete the following templates according the guidelines above:

  • Project description template - Step 1 
  • Milestone template - Step 1 
  • Budget template - Step 1

Please note that completed templates are mandatory submissions as part of a complete proposal.

Project description template - Step 1 

DOCX FORMAT - 49KB

Download

Milestone template - Step 1 

XLSX FORMAT - 31KB

Download

Budget template - Step 1

XLSX FORMAT - 32KB

Download

Supporting documents

More details on policies that are part of the award conditions are available here on the CEPI website:

  • Equitable access policy, including data sharing
  • Shared risks/shared benefits policy
  • Management of intellectual property (IP)
  • Clinical trial policy
  • Cost guidance document (updated version will be available in the week of September 4th)

Step 1 FAQs 1

PDF FORMAT - 259KB

Download

Step 1 FAQs 2

PDF FORMAT - 370KB

Download

Contact

For technical issues with the online application form please contact the Research Council of Norway, and CC CEPI.

For CfP-content related issues please contact CEPI.